Home

jít Cesta Již biologických markerů ras a braf Zaokrouhlit dolů Kdo Výskyt

Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From  Prognostic Marker to Targetable Mutation
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation

Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz

BRAF vs RAS oncogenes: Are mutations of the same pathway equal?  Differential signalling and therapeutic implications | Oncotarget
BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implications | Oncotarget

BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant  Melanoma Cells by Reactivating MEK and ERK Signaling | Science Signaling
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling | Science Signaling

Decision algorithm used in our laboratory for the determination of... |  Download Scientific Diagram
Decision algorithm used in our laboratory for the determination of... | Download Scientific Diagram

Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz

Mutant KRAS can induce either BRAF/BRAF or BRAF-CRAF dimerazaiton of... |  Download Scientific Diagram
Mutant KRAS can induce either BRAF/BRAF or BRAF-CRAF dimerazaiton of... | Download Scientific Diagram

Cancers | Free Full-Text | BRAF V600-Mutated Metastatic Melanoma and  Targeted Therapy Resistance: An Update of the Current Knowledge
Cancers | Free Full-Text | BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge

Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel  Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine  Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David  Malka, Maximiliano Gelli, 2019
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019

BRAF gene: From human cancers to developmental syndromes - ScienceDirect
BRAF gene: From human cancers to developmental syndromes - ScienceDirect

Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz

A) The RAS/BRAF/MEK/ERK and the PI3K/AKT/mTOR pathways and (B) their... |  Download Scientific Diagram
A) The RAS/BRAF/MEK/ERK and the PI3K/AKT/mTOR pathways and (B) their... | Download Scientific Diagram

IJMS | Free Full-Text | The Role of BRAF in Metastatic Colorectal  Carcinoma–Past, Present, and Future
IJMS | Free Full-Text | The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future

Decreased concentrations of intracellular signaling proteins in colon  cancer patients with BRAF mutations | Scientific Reports
Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations | Scientific Reports

Frontiers | Efficacy and safety of a biomarker-driven cetuximab-based  treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF  wild type tumors at start of first line: The CAPRI 2 GOIM
Frontiers | Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM

Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal  transduction pathway in therapy-related myelodysplasia and acute myeloid  leukemia | Leukemia
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Leukemia

CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in  patients treated for metastatic colorectal cancer (mCRC) | British Journal  of Cancer
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer

Cancers | Free Full-Text | Atypical BRAF and NRAS Mutations in Mucosal  Melanoma
Cancers | Free Full-Text | Atypical BRAF and NRAS Mutations in Mucosal Melanoma

BRAF Mutation in Colorectal Cancer Anita Turk, MD; Dustin Deming,  MDDivision of Hematology and Oncology,Department of MedicineUniversity of  Wisconsin-Madison School of Medicine and Public Health and University of  Wisconsin Carbone Cancer Center,
BRAF Mutation in Colorectal Cancer Anita Turk, MD; Dustin Deming, MDDivision of Hematology and Oncology,Department of MedicineUniversity of Wisconsin-Madison School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center,

Frontiers | BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment  Status and Future Perspective
Frontiers | BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective

Cancers | Free Full-Text | Mechanisms of Acquired BRAF Inhibitor Resistance  in Melanoma: A Systematic Review
Cancers | Free Full-Text | Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review

Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz

Frontiers | Implications of BRAF V600E mutation in gliomas: Molecular  considerations, prognostic value and treatment evolution
Frontiers | Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution

The classification of BRAF mutations and their signaling pathways.... |  Download Scientific Diagram
The classification of BRAF mutations and their signaling pathways.... | Download Scientific Diagram

Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic  RAS and BRAF Variants - ScienceDirect
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants - ScienceDirect

Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel  Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine  Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David  Malka, Maximiliano Gelli, 2019
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019

BRAF (gene) - Wikipedia
BRAF (gene) - Wikipedia